Journal of Infection and Chemotherapy Volume 28 Issue 1 to 12

Journal Spotlight: Journal of Infection and Chemotherapy (JIC)

The Journal of Infection and Chemotherapy (JIC) is the official journal of esteemed organizations including the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Infection Prevention and Control. This international journal is dedicated to advancing knowledge in the field of chemotherapy and infection management. Here are the key highlights:

Scope of Coverage:

1. Original Research: JIC welcomes original research papers, whether they are laboratory-based or clinical studies. Research on various aspects of chemotherapy, infection pathogenesis, diagnosis, treatment, and control are within the journal’s scope.
2. Case Reports: The journal provides a platform for sharing valuable case reports that offer insights into the management of infections and the use of anticancer drugs for treatment.
3. Notes: Short but impactful notes on relevant topics in chemotherapy, infection control, and associated fields are encouraged.
4. Committee Reports: Reports from committees in the field of chemotherapy and infectious diseases are featured, providing an overview of their work and findings.
5. Surveillance and Guidelines: The journal publishes research and guidelines related to surveillance practices and guidelines that help healthcare professionals in managing infections.

Epidemiology and Clinical Trials: JIC places a particular emphasis on epidemiological studies and clinical trials. These contributions are vital for understanding disease trends and evaluating the effectiveness of treatments.

Pharmacokinetics and Animal Models: The journal welcomes experimental studies involving animal models and investigations into pharmacokinetics. These studies shed light on drug actions and dosing regimens.

International Collaboration: The journal’s open approach to accepting contributions from around the world promotes international collaboration in the fields of chemotherapy, infectious diseases, and infection prevention.

Official Affiliations: As the official journal of renowned societies and associations in the field, JIC plays a pivotal role in advancing research, disseminating knowledge, and setting standards in chemotherapy and infection management.

Language: While the journal is affiliated with Japanese organizations, it welcomes contributions from all parts of the world in the English language, ensuring that research is accessible to a global audience.

Holistic Approach: By encompassing research from the laboratory to the clinic, JIC provides a holistic view of chemotherapy and infection control, making it a valuable resource for clinicians, researchers, and healthcare professionals worldwide.

Volume 28, Issue 1: Pages 1-128 (January 2022)

Volume 28, Issue 2: Pages 129-362 (February 2022)

Volume 28, Issue 3: Pages 363-472 (March 2022)

Volume 28, Issue 4: Pages 473-594 (April 2022)

Volume 28, Issue 5: Pages 595-722 (May 2022)

Volume 28, Issue 6: Pages 723-844 (June 2022)

Volume 28, Issue 7: Pages 845-1044 (July 2022)

Volume 28, Issue 8: Pages 1045-1224 (August 2022)

Volume 28, Issue 9: Pages 1225-1352 (September 2022)

Volume 28, Issue 10: Pages 1353-1444 (October 2022)

Volume 28, Issue 11: Pages 1445-1594 (November 2022)

Volume 28, Issue 12: Pages 1595-1706 (December 2022)